STOCK TITAN

Affiliate sale notice: 3,750,000 shares proposed (NASDAQ: MLTX)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

The filing discloses a proposed sale of 3,750,000 shares of Common Stock on NASDAQ. The record shows an aggregate offering price of $63,487,500.00 and a reported position of 71,727,875 shares with an as of date of 03/31/2026. The shares include 18,501,284 shares identified as merger consideration acquired on 04/05/2022.

Positive

  • None.

Negative

  • None.

Insights

Form 144 notifies the SEC of an affiliate's intent to sell registered shares.

Form 144 is a regulatory notice required when affiliates propose certain sales of restricted or control securities under Rule 144. The filing lists the proposed quantity, an aggregate offering price, and an ownership snapshot tied to a specific date.

Timing and execution method are not detailed in the excerpt; subsequent public sale activity will appear in broker reports or Form 4/Form 5 filings if applicable.

Shares proposed to be sold 3,750,000 shares Listed under Securities To Be Sold
Aggregate offering price $63,487,500.00 Associated with the proposed sale
Reported position 71,727,875 shares Position listed with date <date>03/31/2026</date>
Merger consideration shares 18,501,284 shares Acquired on <date>04/05/2022</date> as merger consideration
Form 144 regulatory
"Proposed sale notice for affiliate sales of restricted/control stock"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
merger consideration financial
"Merger consideration relating to the Issuer's business combination"
Merger consideration is the total payment a company or buyer offers to shareholders of a target company in exchange for combining the two businesses, and can include cash, shares in the surviving company, debt assumption, or a mix of these. Investors care because the form and amount affect the deal’s value, tax consequences, immediate cash received versus future ownership, and the risk and upside of holding new shares — similar to choosing between cash now or stock that could grow later.
aggregate offering price financial
"63487500.00 listed next to the proposed sale quantity"
The aggregate offering price is the total dollar amount that will be raised if all the securities in an offering are sold at the stated offering price, before fees or expenses are taken out. Investors use it to gauge the size of the fundraising and its potential effects—such as how much cash the company will get and how much existing ownership might be reduced—similar to totaling every item’s price in a shopping cart to see the full bill.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the MLTX Form 144 disclose?

The filing discloses a proposed sale of 3,750,000 shares of Common Stock and an aggregate offering price of $63,487,500.00. It also lists ownership and acquisition details with an as of date of 03/31/2026.

Who appears as the broker or placement agent in the MLTX Form 144?

The excerpt names Goldman Sachs & Co. LLC with an address at 200 West Street, New York. The filing shows broker identification but does not describe sales mechanics or timing in this excerpt.

Are these MLTX shares newly issued or from a prior merger?

The filing states 18,501,284 shares were acquired upon automatic conversion as merger consideration on 04/05/2022. That line ties a portion of the holdings to the issuer's business combination.

Does the Form 144 indicate when the sale will occur?

No specific sale date or execution timetable is provided in the excerpt. The document shows the proposed quantity and an as of date of 03/31/2026, but not the timing of transactions.

Will this Form 144 change MLTX's outstanding share count?

The filing reports an ownership snapshot of 71,727,875 shares as of 03/31/2026. It does not state any change to authorized or outstanding shares; it only notifies of a proposed affiliate sale.
MoonLake Immunotherapeutics

NASDAQ:MLTX

View MLTX Stock Overview

MLTX Rankings

MLTX Latest News

MLTX Latest SEC Filings

MLTX Stock Data

1.21B
64.24M
Biotechnology
Pharmaceutical Preparations
Link
Switzerland
ZUG